1-4 of 4
Attila Kiss
Close
Sort by
Journal Articles

Retrospective Comparison Of Autologous Transplantation Results Of Decreased MNC Viability Graft Cases (n=52) To Good Viability Graft Cases (n=306), a Single Centre Experience

Mariann Szarvas, Gabriella Kovács, Zita Korondán, Peter Batar, MD, PhD, Attila Kiss, MD, PhD, László Rejtö, MD, PhD, Gyula Reményi, MD, Róbert Szász, MD, László Váróczy, MD, PhD, Árpád Illés, MD, PhD, DSc, Miklós Udvardy, MD, PhD, DSc
Journal: Blood
Blood (2013) 122 (21): 2164.
https://doi.org/10.1182/blood.V122.21.2164.2164
Published: 2013
Journal Articles

The Effect of Bortezomib Containing Induction On the Long Term Outcome of autologous Haemopoietic Stem Cell Transplantation in Multiple Myeloma Patients Outside Clinical Trials - a Single Center Experience

Miklos Udvardy, MD, PhD, Remenyi Gyula, Attila Kiss, Prof. Dr., Peter Batar, Dr, Arpad Illes, MD, PhD, Dsc, Laszló Varoczy, MD PhD, Gaspar Radvanyi, MD, Robert Szasz, PhD, MD, Laszlo Rejto, PhD, MD
Journal: Blood
Blood (2012) 120 (21): 5050.
https://doi.org/10.1182/blood.V120.21.5050.5050
Published: 2012
Journal Articles

A New Approach to Predict the Chance of Infectious Complications Following Autologous Hematopoietic Stem Cell Transplantation: Mannose-Binding Lectin ELISA

Zita Radnay, MD, Miklos Udvardy, PhD, MD, Attila Kiss, PhD, MD, Maria Papp, PhD, MD, Laszlo Rejto, PhD, MD, Jolan Harsfalvi, PhD, Tamas Masszi, MD, PhD, Robert Szasz, PhD, MD, Peter Batar, MD, PhD, Gyula Remenyi, MD, Bela Telek, PhD, MD
Journal: Blood
Blood (2011) 118 (21): 4492.
https://doi.org/10.1182/blood.V118.21.4492.4492
Published: 2011
Journal Articles

Bortezomib+Chemotherapy Based Salvage Combinations in Refractory AML, Preliminary Results

Miklos Udvardy, Attila Kiss, Bela Telek, Robert Szasz, Peter Batar, Gyula Remenyi, Andrew Cakana, Laszlo Rejto
Journal: Blood
Blood (2008) 112 (11): 4000.
https://doi.org/10.1182/blood.V112.11.4000.4000
Published: 2008